Armata Pharmaceuticals (ARMP) Financial Statements

Compare

297 Followers

Armata Pharmaceuticals Financial Overview

Armata Pharmaceuticals's market cap is currently $306.62M. The company's EPS TTM is $-3.42; its P/E ratio is -0.46; Armata Pharmaceuticals is scheduled to report earnings on March 25, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	$ 4.90M	$ 5.17M	$ 4.53M	$ 5.51M	$ 4.47M
Gross Profit	$ 3.37M	$ -29.25M	$ 3.56M	$ -29.51M	$ -15.54M
Operating Income	$ -31.22M	$ -42.44M	$ -40.89M	$ -36.95M	$ -23.82M
EBITDA	$ -29.69M	$ -41.11M	$ -65.45M	$ -36.05M	$ -21.92M
Net Income	$ -173.80M	$ -18.92M	$ -69.05M	$ -36.92M	$ -23.16M
Balance Sheet
Cash & Short-Term Investments	$ 8.69M	$ 9.29M	$ 13.52M	$ 14.85M	$ 10.29M
Total Assets	$ 76.88M	$ 86.44M	$ 98.36M	$ 107.88M	$ 69.77M
Total Debt	$ 288.02M	$ 126.52M	$ 120.37M	$ 48.81M	$ 37.99M
Net Debt	$ 279.33M	$ 117.22M	$ 106.85M	$ 33.96M	$ 27.70M
Total Liabilities	$ 295.48M	$ 134.46M	$ 130.43M	$ 71.80M	$ 44.37M
Stockholders' Equity	$ -218.60M	$ -48.02M	$ -32.06M	$ 36.08M	$ 25.40M
Cash Flow
Free Cash Flow	$ -26.30M	$ -39.43M	$ -55.57M	$ -34.69M	$ -24.88M
Operating Cash Flow	$ -25.76M	$ -37.55M	$ -47.42M	$ -32.48M	$ -23.57M
Investing Cash Flow	$ -542.00K	$ -1.88M	$ -8.13M	$ -2.21M	$ -1.30M
Financing Cash Flow	$ 25.61M	$ 34.96M	$ 53.99M	$ 44.02M	$ 25.52M

Currency in USD

Armata Pharmaceuticals Earnings and Revenue History

Income Statement >

Armata Pharmaceuticals Debt to Assets

Balance Sheet >

Armata Pharmaceuticals Cash Flow

Cash Flow >

Armata Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >